Cas:53254-53-8 17-Methyl-nonadecanoic acid manufacturer & supplier

Chemical Name:17-Methyl-nonadecanoic acid

CAS.NO:53254-53-8

Synonyms:17-Methyl-nonadecanoic acid

Molecular Formula:C₂₀H₄₀O₂

Molecular Weight:312

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 17-Methyl-nonadecanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,17-Methyl-nonadecanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,17-Methyl-nonadecanoic acid Use and application,17-Methyl-nonadecanoic acid technical grade,usp/ep/jp grade.

Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 17-Methyl-nonadecanoic acid manufacturer Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 17-Methyl-nonadecanoic acid supplier On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 17-Methyl-nonadecanoic acid vendor On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 17-Methyl-nonadecanoic acid factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.